Spirometry for Asthma and COPD - A strategic path forward for IDNs
The Challenge: Undiagnosed lung disease comes at a cost #
Asthma and COPD continue to place a massive burden on patients, providers, and health systems, largely due to underdiagnosis and delayed intervention.
- Over 40 million Americans are affected by asthma and COPD, driving $100B in annual healthcare costs.1
- Up to 33% of asthma patients and 62% of COPD patients are misdiagnosed when spirometry is not used.2
- Nearly 20% of COPD patients are readmitted within 30 days, triggering costly CMS penalties.3
Without objective lung function testing, care decisions are often reactive instead of proactive—leading to poor outcomes and avoidable costs.
The Solution: Why spirometry matters #
Spirometry is the foundation of accurate diagnosis and effective long-term respiratory care. When used consistently, it improves outcomes, reduces costs, and supports health system performance goals.
Clinical value #
- Enables objective diagnosis of asthma and COPD
- Establishes baseline lung function for ongoing tracking
- Supports earlier intervention and proactive disease management
Financial value #
- Helps reduce hospital readmissions and associated penalties
- Aligns with HEDIS, MIPS, and CMS quality measures
- Supports value-based care and performance-driven reimbursement
Equity & access #
- Expands access to accurate diagnostics
- Helps close care gaps in underserved and at-risk populations
- Promotes more equitable respiratory care across settings
Why ndd EasyOne Solutions #
ndd EasyOne spirometers are designed to make spirometry practical, scalable, and financially impactful, without adding complexity.
Generate over $40,000 per year per device by testing just 100 patients per month! (Try our PFT calculator to see your potential today)
Scalable deployment across clinics, healthcare systems, and care settings
HITRUST e1 certified with nddCloud, ensuring data protection and compliance
Delivers clinical and financial value without compromising security
A path toward better COPD care starts today with the EasyOne solutions.
Request your demo
T. AARON ZELLER, MD, KATHERINE BEBEN, MD, AND STEPHANIE WALKER, MD. Am Fam Physician. 2023;107(3):247-252 ↩︎
Shawn D. Aaron, MD1; Katherine L. Vandemheen, MScN1; J. Mark FitzGerald, MD2 et al JAMAPublished Online: January 17, 2017 2017;317;(3):269-279. doi:10.1001/jama.2016.19627 ↩︎
Jacobs, D. M., Noyes, K., Zhao, J., Gibson, W., Murphy, T. F., Sethi, S., & Ochs-Balcom, H. M. (n.d.). Early hospital readmissions after an acute exacerbation of chronic obstructive pulmonary disease in the nationwide readmissions database. Annals of the American Thoracic Society. https://pubmed.ncbi.nlm.nih.gov/29611719/ ↩︎
